Test Price
2,800 AED✅ Home Collection Available
DST Gene (Epidermolysis Bullosa Simplex, Autosomal Recessive Type 2) Genetic Test in UAE | 2800 AED | DHA Licensed Lab 1143
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity – ISO-certified NGS processing validated against international reference standards.
- VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily from 8 AM to 11 PM.
- Post-Test Clinical Guidance – Telephonic specialist interpretation by DHA-licensed genetics consultant.
- Direct Insurance Billing – Verify instantly via WhatsApp: +971 54 548 8731.
This test provides a definitive molecular diagnosis for autosomal recessive epidermolysis bullosa simplex type 2, aiding in clinical management and genetic counselling.
Test Overview & Methodology
This advanced Next‑Generation Sequencing (NGS) screen targets the full coding region of the DST gene, identifying pathogenic variants responsible for autosomal recessive epidermolysis bullosa simplex type 2. The test offers 99.9% analytical sensitivity and complete gene coverage using Illumina® technology with a bioinformatic pipeline specialised for DST.
| Feature | Our DST NGS Test | Closest Alternative* |
|---|---|---|
| Precision | 99.9% Analytical Sensitivity, full gene coverage | Variable; often limited to hotspot panels |
| Methodology | Illumina® NGS with bioinformatic DST‑specific pipeline | Sanger sequencing (single exon focus) |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
*Based on regional lab surveys. Alternative does not reflect identical scope.
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I see the profound impact a definitive molecular diagnosis can have on families navigating rare skin fragility disorders. This NGS test for the DST gene is a cornerstone of precision medicine, but its results must always be interpreted by a qualified genetics professional in the context of clinical findings and family history. Genetic counselling before and after testing is essential for informed decision‑making.”
— Lina Osama Zaki Quteineh (DHA License 9294403)
Medication Safety Notice
Important Advisory
Do not discontinue prescribed medication without consulting your doctor. Any changes in treatment must be guided by the physician who manages your skin condition.
Exclusion Criteria & Safety Red Flags
Emergency Red Flags — Seek Immediate Care If You Experience:
- Sudden widespread blistering with fever or signs of infection
- Difficulty swallowing or breathing due to oral/mucosal involvement
- Severe pain unresponsive to prescribed analgesics
Exclusion criteria for home collection: active skin infection at collection site, refusal of genetic counselling consent, or recent blood transfusion (<3 weeks).
Patient FAQ & Clinical Guidance
1. What does a positive DST gene result mean for my epidermolysis bullosa simplex diagnosis?
Clinical Snippet: A positive, pathogenic DST variant confirms the genetic cause of autosomal recessive epidermolysis bullosa simplex type 2 with 99.9% diagnostic certainty. This molecular confirmation helps guide management, prognosis, and family counselling.
2. How should I prepare for the blood draw and genetic counselling session?
Clinical Snippet: No fasting is required. Simply provide a fresh whole blood sample and be ready to share a detailed three‑generation family history of skin fragility. Genetic counselling will be arranged before and after the test.
3. Is this test safe for children, and what are the consent requirements in the UAE?
Clinical Snippet: The test is minimally invasive and child‑safe when performed by a trained paediatric phlebotomist. Parental consent, genetic counselling, and full compliance with UAE Federal Decree‑Law No. 4 of 2016 on Medical Liability are mandatory for minors.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE fully complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is processed with strict confidentiality, encrypted storage, and access controls. The laboratory holds DHA License 1143 and operates under the regulatory oversight of the Dubai Health Authority.
Clinical & Logistical Metadata
| Test Name | DST Gene (Epidermolysis Bullosa Simplex, Autosomal Recessive Type 2) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (peripheral) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Illumina with bioinformatic DST‑specific pipeline |
| ICD-10-CM Code | Q81.0 |
| LOINC Code | 81413-0 |
| DHA Facility License & Laboratory Address | 1143 – DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians